Protocols
Locally Advanced Disease
HNNLAPG
Induction Treatment of Locally Advanced Nasopharyngeal Cancer with CISplatin and Gemcitabine
HNNLAPRT
Treatment of Locally Advanced Nasopharyngeal Cancer with Concurrent CISplatin and Radiation
Advanced Disease
HNNAVCAP
Treatment Of Recurrent Or Metastatic Nasopharyngeal Cancer With Capecitabine
HNNAVFUFA
Treatment of Recurrent or Metastatic Nasopharyngeal Cancer with Fluorouracil and Leucovorin
HNNAVFUP
Treatment for Advanced Nasopharyngeal Cancer of the Head and Neck using Platinum and Fluorouracil
HNNAVGEM
Treatment of Loco-regionally Recurrent/Metastatic Nasopharyngeal Cancer Not Amenable for Local Curative Therapy with Gemcitabine
HNNAVP
Palliative Chemotherapy for Advanced Head and Neck Nasopharyngeal Carcinoma with Weekly CISplatin
HNNAVPC
Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma with CARBOplatin and PACLitaxel
HNNAVPE
Treatment of Recurrent and/or Metastatic Nasopharyngeal Cancer with Platinum and Etoposide
HNNAVPG
Treatment of Locoregionally Recurrent and/or Metastatic Nasopharyngeal Cancer with Platinum and Gemcitabine
Top
Locally Advanced Disease
HNLAALTPRT
Treatment of Locally Advanced (Alternate) Head and Neck Cancer Using CISplatin during Radiation Therapy
HNLACART
(see HNLACARTW)
HNLACART3
Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with Concurrent 3-Weekly CARBOplatin and Radiation
HNLACARTW
Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with Concurrent Weekly CARBOplatin and Radiation
HNLAPRT
Combined Chemotherapy (CISplatin) and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of The Head and Neck
HNLACAFRT
Combined Chemotherapy (CARBOplatin and Fluorouracil) and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
HNLACETRT
Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
HNLADCF
Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck with DOCEtaxel, CISplatin and Infusional Fluorouracil
Advanced Disease
HNAVCAP
Treatment Of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck With Capecitabine
HNAVDOC
Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with DOCEtaxel
HNAVFUFA
Fluorouracil and Leucovorin for Recurrent Head and Neck Cancer (Squamous Cell Carcinoma)
HNAVFUP
Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum
HNAVM
Treatment of Head and Neck Cancer Using Methotrexate as Standard Therapy
HNAVNIV
Palliative Therapy for Unresectable, Platinum-refractory, Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Using Nivolumab
Palliative Therapy for Unresectable, Platinum-refractory, Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Using 4-Weekly Nivolumab
HNAVP
Palliative Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma with Weekly CISplatin
HNAVPC
Treatment for Unresectable, Locoregionally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Using PACLitaxel and CISplatin or CARBOplatin
HNAVPCPMB
First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck with PACLitaxel, CARBOplatin and Pembrolizumab
HNAVPD
Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with Platinum and DOCEtaxel
HNAVPE
Treatment of Recurrent and Metastatic Squamous Cell Cancer with Platinum and Etoposide
HNAVPFPMB
First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Using Platinum, Fluorouracil and Pembrolizumab
HNAVPMBF
First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck with Pembrolizumab
HNAVPMBF6
First-Line Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck using 6-Weekly Pembrolizumab
HNAVPMBM
Maintenance Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck with Pembrolizumab
HNAVPMBM6
Maintenance Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck using 6-Weekly Pembrolizumab
Top
HNOTDCABO
Therapy of Advanced Differentiated Thyroid Cancer using Cabozantinib
HNOTAVD
Palliative Therapy for Advanced Thyroid Cancers Using DOXOrubicin
HNOTDSEL
Therapy of Advanced RET Fusion-Positive Differentiated Thyroid Cancer using Selpercatinib
HNOTLEN
Therapy for Locally Recurrent or Metastatic, RAI-refractory Differentiated Thyroid Cancer Using Lenvatinib
HNOTMSEL
Treatment of Advanced RET-Mutant Medullary Thyroid Cancer using Selpercatinib
HNOTTSH
Radioiodine Imaging in Patients with Thyroid Cancer using Thyrotropin Alpha
HNOTVAN
Treatment for Locally Advanced or Metastatic Medullary Thyroid Cancer Using vanDETanib
Top
HNSAVFAC
Palliative Therapy for Advanced Salivary Gland Cancers Using Cyclophosphamide, DOXOrubicin and Fluorouracil
HNSAVFUP
Treatment of Advanced Head and Neck Cancer Using CISplatin and Fluorouracil
HNSAVNP
Treatment of Advanced Salivary Gland Cancers With CISplatin and Vinorelbine
HNSAVPAC
Treatment of Advanced Salivary Gland Cancers With Platinum, DOXOrubicin and Cyclophosphamide
HNSAVTAM
Treatment of Recurrent/Metastatic Salivary Gland Cancers of the Head and Neck With Tamoxifen